Additionally, CD4+ CAR T cells showed persistent tumor challenge and effective function, whereas CD8+ CAR T cells were exhausted immediately after expressing their effective function following stimulation with IL13Rα2+ glioblastoma (GBM) cells. The gene discussed is CD8A; the disease is glioblastoma.